Company / SG&A Expense
LifeStance Health Group, Inc. SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$382.2M
FY2025
5-year range
$363.1M / $433.7M
FY2021-FY2025
Trend
+5.3%
vs FY2024
Sector context
#79 of 152
Health Care
What the data says
At $382M, LifeStance Health Group, Inc.'s sg&a expense ranks #74 of 152 in the Health Care sector. SG&A Expense has fluctuated over the past 7 years, ranging from $41M in FY2019 to $434M in FY2021.
Based on SEC 10-K filings.
$382M in FY2025 with a 5-year CAGR of +49.1%.
Improved from $411M to $382M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- +49.1%
- 10-Year CAGR
- -
Sector benchmark
#74 of 152 in Health CareTop 48% of 152This company $382.2M Sector average $182.7B
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +49.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 5.3% year-over-year.
- Ranks #79 out of 152 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $382.2M | +5.3% |
| FY2024 | $363.1M | -11.6% |
| FY2023 | $410.8M | +8.7% |
| FY2022 | $378.0M | -12.8% |
| FY2021 | $433.7M | +736.6% |
| FY2020 | $51.8M | +26.3% |
| FY2019 | $41.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026